These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Losartan--a new antihypertensive. Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558 [No Abstract] [Full Text] [Related]
24. [Clinical studies on differential therapy of hypertension with dichlorophenylaminoimidazoline hydrochloride (Haemiton)]. Seifert A; Hafemeister G; Kirchner D; Wöstenberg D; Tiedcke H; Ullmann W Dtsch Gesundheitsw; 1970 Dec; 25(50):2369-74. PubMed ID: 5509665 [No Abstract] [Full Text] [Related]
25. [On the therapy of hypertension with an imidazoline derivative]. Krause W; Krämer D; Grünitz B Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785 [No Abstract] [Full Text] [Related]
26. Safety and efficacy of moxonidine in mild to moderate hypertension. Jain S; Malhotra P; Kumari S; Varma S J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474 [TBL] [Abstract][Full Text] [Related]
27. [First clinical experiences with a new hypotensive substance in severe forms of hypertension]. Bergström J; Bergquist-Poppen M; Bucht H Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792 [No Abstract] [Full Text] [Related]
28. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension. Levine B Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450 [TBL] [Abstract][Full Text] [Related]
29. Properties of catapres, a new hypotensive drug: a preliminary report. Ng J; McGrgor DD; Taylor KM; Smirk H N Z Med J; 1967 Dec; 66(425):864-70. PubMed ID: 5236015 [No Abstract] [Full Text] [Related]
30. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance]. Haan D Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739 [No Abstract] [Full Text] [Related]
31. [Controlling blood pressure by centrally acting drugs--still a topic?]. Steckelings UM; Unger T Fortschr Med; 1994 Jan; 112(3):25-6. PubMed ID: 8144121 [No Abstract] [Full Text] [Related]
32. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study. Sharma AM; Wagner T; Marsalek P J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of severe hypertension with Catapresan. A comparative study of the effects of Catapresan and methyldopa on ambulant hypertensive patients]. Becker-Christensen F; Bang HO; Ditzel J Ugeskr Laeger; 1970 Dec; 132(49):2331-6. PubMed ID: 5488234 [No Abstract] [Full Text] [Related]
35. [Use of St 155 in chronic renal insufficiency with arterial hypertension]. Previgliano H; Challu A; Junemann A; Rodano J; Marchand M; Taype E; Gonzalez Ortiz R; Lammirato G; Rodrigues C; Gallardo R; De Felipe C; De la Riestra N Prensa Med Argent; 1971 Jul; 58(22):1117-9. PubMed ID: 5097755 [No Abstract] [Full Text] [Related]
36. A comparative trial of timolol and flutonidin as antihypertensive agents. Salvadeo A; Segagni S; Villa G; Galli F; Piazza W; Bovio G Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):78-84. PubMed ID: 7037661 [TBL] [Abstract][Full Text] [Related]
37. [Clinical aspects of antihypertensive drug therapy]. Arabidze GG; Bogoslovskiĭ VA Ter Arkh; 1982; 54(3):134-46. PubMed ID: 6124049 [No Abstract] [Full Text] [Related]